Aigen Investment Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,755
Closed -$793K 565
2026
Q1
$793K Sell
3,755
-8,199
-69% -$1.77M 0.2% 136
2025
Q4
$2.46M Buy
+11,954
New +$2.25M 0.57% 39
2025
Q3
Sell
-15,176
Closed -$2.55M 816
2025
Q2
$2.55M Sell
15,176
-12,184
-45% -$1.81M 0.35% 59
2025
Q1
$3.77M Buy
27,360
+3,156
+13% +$402K 0.6% 17
2024
Q4
$2.86M Buy
+24,204
New +$2.83M 0.5% 32
2024
Q3
Sell
-16,957
Closed -$1.67M 759
2024
Q2
$1.67M Buy
+16,957
New +$1.73M 0.32% 69
2021
Q2
Sell
-7,248
Closed -$440K 492
2021
Q1
$440K Buy
+7,248
New +$400K 0.06% 317
2020
Q2
Sell
-10,643
Closed -$510K 867
2020
Q1
$510K Buy
10,643
+8,554
+409% +$444K 0.07% 413
2019
Q4
$106K Buy
+2,089
New +$108K 0.02% 672

Other funds holding CAH

Aigen Investment Management's CAH Position: Q2 2026 in Review

Aigen Investment Management sold out of Cardinal Health (CAH) in Q2 2026, closing a stake of 3,755 shares — an estimated $793K sold.

Aigen Investment Management first reported a position in CAH in Q4 2019 and held it in 9 quarters. The position peaked at $3.77M in Q1 2025. 1,490 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Aigen Investment Management reported no remaining Cardinal Health position as of Q2 2026 after selling out during the quarter.
  • Aigen Investment Management sold 3,755 Cardinal Health shares in Q2 2026, an estimated $793K.
  • Aigen Investment Management first reported a position in Cardinal Health in Q4 2019 and held it in 9 quarters.
  • Aigen Investment Management's Cardinal Health position peaked at $3.77M in Q1 2025.
  • 1,490 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Aigen Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.